Search

Drug Profiles Catalysts Company Profiles Impact Events Target
Indication Trials KOL Insight Special Reports All

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
10/23/14 Cellceutix (CTIX) Brilacidin for Skin and Skin-Structure Infections (Antibacterial) Subscribers Only Subscribers Only Subscribers Only
10/23/14 Novartis (NVS) Cosentyx for Ankylosing Spondylitis Subscribers Only Subscribers Only Subscribers Only
10/22/14 Regulus (RGLS) RG-101 for Hepatitis C (HCV) (Antiviral) Subscribers Only Subscribers Only Subscribers Only
10/22/14 Cytori Thereapeutics (CYTX) Cytori Cell Therapy for Coronary Artery Disease Subscribers Only Subscribers Only Subscribers Only
10/22/14 Relypsa (RLYP) Patiromer for Hyperkalemia Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
10/24/14 Subscribers Only Subscribers Only Regulatory - CHMP (European Panel) Supplemental Filing Results
10/24/14 Subscribers Only Subscribers Only Regulatory - CHMP (European Panel) Supplemental Filing Results
10/24/14 Subscribers Only Subscribers Only Regulatory - CHMP (European Panel) Supplemental Filing Results
10/24/14 Subscribers Only Subscribers Only Regulatory - Supplemental Approval (Europe)
10/24/14 Subscribers Only Subscribers Only Regulatory - CHMP (European Panel) Results